Sort
16,300 grants matching “fatty liver disease”
Advanced Assessment of Hepatic Inflammation and Fibrosis with MR Elastography
$350,595Meng Yin · Mayo Clinic Rochester · R01 · FY2015 · EB
Comprehensive noninvasive assessment of liver histopathology in nonalcoholic fatty liver disease (NAFLD) via magnetic resonance imaging, cytometry and elastography (MR-ICE)
$350,595Meng Yin · Mayo Clinic Rochester · R01 · FY2024 · EB
Advanced Assessment of Hepatic Inflammation and Fibrosis with MR Elastography
$350,595Meng Yin · Mayo Clinic Rochester · R01 · FY2021 · EB
Transcription cycle regulation by nutrients
$350,569Nuria Morral · Indiana University Indianapolis · R01 · FY2023 · DK
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
$350,513Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2013 · DK
Fine-tuning lipid metabolism by LSD1
$350,513Fajun James Yang · Albert Einstein College Of Medicine · R01 · FY2013 · DK
Targeting Uric Acid as a Therapeutic for NASH
$350,505Nicholas Khoo · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Mechanisms of Regulation of Retinoic Acid Homeostasis
$350,428Nina Isoherranen · University Of Washington · R01 · FY2020 · GM
Stress Signaling Pathways in Toxicity and Disease
$350,384Michael Karin · University Of California, San Diego · R01 · FY2010 · ES
Nitrated fatty acids/PPARgamma in the control of renal and vascular functions
$350,305Tianxin Yang · University Of Utah · R01 · FY2009 · DK
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations
$350,258Veronica Wendy Setiawan · University Of Southern California · R01 · FY2021 · CA
Project 1: Control of NASH to HCC progression by the NRF2-FBP1 tug-of-war
$350,066Michael Karin · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · CA
Expression of the type 3 InsP3 receptor in the injured hepatocyte: mechanisms and effects
$350,035Michael H Nathanson · Yale University · P01 · FY2020 · DK
Expression of the type 3 InsP3 receptor in the injured hepatocyte: mechanisms and effects
$350,033Michael H Nathanson · Yale University · P01 · FY2017 · DK
Expression of the type 3 InsP3 receptor in the injured hepatocyte: mechanisms and effects
$350,033Michael H Nathanson · Yale University · P01 · FY2019 · DK
Pediatric Trials in Non-Alcoholic Steatohepatitis (NASH)
$350,000University Of California San Diego · U01 · FY2003 · DK
Omega 3 Fatty Acids Acute Neuroprotection via Mitochondria
$350,000Richard J Deckelbaum · Columbia University Health Sciences · R01 · FY2015 · NS
Omega 3 Fatty Acids Acute Neuroprotection via Mitochondria
$350,000Richard J Deckelbaum · Columbia University Health Sciences · R01 · FY2016 · NS
Pediatric Trials in Non-Alcoholic Steatohepatitis (NASH)
$350,000University Of California San Diego · U01 · FY2002 · DK
Multi-omics study of ancestry enriched associations in Hispanics/Latinos
$350,000Nora Franceschini · Univ Of North Carolina Chapel Hill · R56 · FY2023 · HG
Omega 3 Fatty Acids Acute Neuroprotection via Mitochondria
$350,000Richard J Deckelbaum · Columbia University Health Sciences · R01 · FY2019 · NS
Omega 3 Fatty Acids Acute Neuroprotection via Mitochondria
$350,000Richard J Deckelbaum · Columbia University Health Sciences · R01 · FY2017 · NS
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center
$350,000James A Tonascia · Johns Hopkins University · U24 · FY2020 · DK
Preclinical validation of AVGN7 for treating obesity and type 2 diabetes mellitus.
$350,000Buel Rodgers · Aavogen, Inc. · R43 · FY2025 · DK
Immune regulation of adipose tissue mass
$349,929Anthony W Ferrante · Columbia University Health Sciences · R01 · FY2015 · DK